Company / Current Assets
Intellia Therapeutics, Inc. Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$527.7M
FY2025
5-year range
$527.7M / $1.2B
FY2021-FY2025
Trend
-17.5%
vs FY2024
Sector context
#112 of 165
Health Care
What the data says
At $528M, Intellia Therapeutics, Inc.'s current assets ranks #112 of 165 in the Health Care sector. Current Assets has declined for 3 consecutive years, from $1.2B in FY2022 to $528M in FY2025.
Based on SEC 10-K filings.
$528M in FY2025 with a 5-year CAGR of -3.1%.
Declined from $998M to $528M over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- -24.3%
- 5-Year CAGR
- -3.1%
- 10-Year CAGR
- -
Sector benchmark
#112 of 165 in Health CareTop 68% of 165This company $527.7M Sector average $5.2B
▼
-89.9% below sector average
Key checks
Key Insights
- Intellia Therapeutics, Inc.'s current assets has declined for 3 consecutive years.
- 5-year CAGR of -3.1%, indicating a declining trend.
- In FY2025, current assets decreased 17.5% year-over-year.
- Ranks #112 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -2.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $527.7M | -17.5% |
| FY2024 | $639.9M | -35.9% |
| FY2023 | $998.3M | -18.0% |
| FY2022 | $1.2B | +58.2% |
| FY2021 | $769.3M | +24.8% |
| FY2020 | $616.5M | +113.0% |
| FY2019 | $289.5M | -10.9% |
| FY2018 | $325.0M | -8.4% |
| FY2017 | $354.8M | +26.1% |
| FY2016 | $281.3M | +262.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026